Cargando…
GSK-3β Regulates the Expression of P21 to Promote the Progression of Chordoma
PURPOSE: Chordoma is a rare malignant bone tumor transformed from the remnants of notochord. It is characterized as highly aggressive and locally invasive, difficult to be completely removed by surgery, and has a poor clinical prognosis. Glycogen synthase kinase 3 beta (GSK-3β) is involved in many c...
Autores principales: | Chen, Li, Zuo, Yi, Pan, Ru, Ye, Zhen, Wei, Kailun, Xia, Shaohuai, Li, Wencai, Tan, Jie, Xia, Xuewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810826/ https://www.ncbi.nlm.nih.gov/pubmed/33469364 http://dx.doi.org/10.2147/CMAR.S289883 |
Ejemplares similares
-
MiR-17 and miR-93 Promote Tumor Progression by Targeting p21 in Patients with Chordoma
por: Dong, Wei, et al.
Publicado: (2021) -
Factors for tumor progression in patients with skull base chordoma
por: Wang, Liang, et al.
Publicado: (2016) -
Long noncoding RNA SNHG20 promotes gastric cancer progression by inhibiting p21 expression and regulating the GSK-3β/ β-catenin signaling pathway
por: Liu, Jie, et al.
Publicado: (2017) -
Systemic immune inflammation index and peripheral blood carbon dioxide concentration at admission predict poor prognosis in patients with severe traumatic brain injury
por: Chen, Li, et al.
Publicado: (2023) -
Erlotinib Inhibits Growth of a Patient-Derived Chordoma Xenograft
por: Siu, I-Mei, et al.
Publicado: (2013)